drugset / Trial / NCT00849056
Safety and Efficacy of Albiglutide in Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability and efficacy of albiglutide in the treatment of type 2 diabetes.
Timeline
- Start
- 2009-01
- Primary completion
- 2011-11
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | albiglutide | Peptide | — | Subcutaneous |